Elham Kamangar, MD
Pathology · Barberton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Summit Pathology Associates, Inc · 12 clinicians in this group
Hospitals listed: Crystal Clinic Orthopaedic Center · Summa Health System. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kamangar’s office at (330) 615-3000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A143605 · Current
Licensed to practise in California · since 2016 · expires 2028-07-31 · Kashan University of Medical Sciences and Health Services.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Crystal Clinic Orthopaedic CenterAkron, OHAcute Care Hospital · Proprietary · No emergency departmentPatients rate it 5 of 5 · 88% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.5 to 1) · 899 cases, Jan 2024 – Dec 2024
- Summa Health SystemAkron, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Summa Health System, which runs 3 hospitalsPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.32 (1.05 to 1.58), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.06 (1.51 to 2.6) · 7,424 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 119.8 (75.55 to 164.05) · 106 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.464, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.311, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.374, Oct 2024 – Sep 2025
See every measure and the patient survey for Crystal Clinic Orthopaedic Center
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 2 the same, 1 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.5 to 1) · 899 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.11) · 346 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.32 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 858 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,458 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 1,426 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.71 (0.54 to 4.88) · 1,441 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 1,400 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.98 to 4.2) · 1,418 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.25 (0 to 12.86) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4 (0.2 to 7.79) · 1,372 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.23 to 3.28) · 283 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.49 (0 to 1.67) · 497 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 791 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.837 | No different | Oct 2024 – Sep 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 781 cases | None | Jul 2023 – Jun 2025 |
What patients said (609 patients answered, 54% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 89% |
| Doctors "always" communicated well | 86% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 92% |
| Doctors "always" explained things so they could understand | 83% |
| Doctors "always" listened carefully | 85% |
| Doctors "always" treated them with courtesy and respect | 90% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 84% |
| Nurses "always" explained things so they could understand | 85% |
| Nurses "always" listened carefully | 89% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 72% |
| "YES", patients would definitely recommend the hospital | 88% |
| Staff "always" explained possible side effects | 56% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Summa Health System
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 3 the same, 2 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.32 (1.05 to 1.58) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.06 (1.51 to 2.6) · 7,424 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 119.8 (75.55 to 164.05) · 106 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.464 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.311 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.374 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.2 (0.34 to 2.06) · 1,783 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.5 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.7 · 401 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.2 · 683 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 6,330 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.08 to 0.46) · 8,914 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.07 to 0.44) · 9,237 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.9 (2.08 to 5.73) · 2,198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.19 (0 to 2.66) · 1,030 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.66 (2.31 to 5.01) · 2,071 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.81 (0.54 to 11.08) · 1,008 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.31 (1.15 to 7.47) · 1,016 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.67 to 3.48) · 562 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 45 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.789 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.763 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 413 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,565 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 2.8 · 149 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.3 · 601 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 416 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.4 · 1,236 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4.5 to 9) · 188 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.1 (9.2 to 15.8) · 188 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 44 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 643 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (11.3 to 18.4) · 1,066 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 777 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,943 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$67,072
Medicare paid this office $67,072 for 808 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 598 | $34,428 | $26 |
| Special stained specimen slides to examine tissue, initial procedure | 272 | $7,426 | $25 |
| Special stained specimen slides to examine tissue, each additional procedure | 79 | $6,245 | $21 |
| Pathology examination of tissue using a microscope, moderately high complexity | 38 | $3,827 | $60 |
| Microscopic genetic analysis of tumor, manual | 31 | $2,862 | $32 |
See all 14 services
| Pathology examination of tissue using a microscope, intermediate complexity | 598 | $34,428 | $26 |
| Special stained specimen slides to examine tissue, initial procedure | 272 | $7,426 | $25 |
| Special stained specimen slides to examine tissue, each additional procedure | 79 | $6,245 | $21 |
| Pathology examination of tissue using a microscope, moderately high complexity | 38 | $3,827 | $60 |
| Microscopic genetic analysis of tumor, manual | 31 | $2,862 | $32 |
| Blood smear interpretation by physician with written report | 101 | $1,841 | $18 |
| Cell examination of specimen, selective cellular enhancement technique | 48 | $1,157 | $20 |
| Evaluation of fine needle aspirate with interpretation and report | 18 | $973 | $51 |
| Preparation of tissue for examination by removing any calcium present | 103 | $916 | $9 |
| Special stained specimen slides to examine tissue including interpretation and report | 87 | $899 | $9 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $411 | $20 |
| Examination of archival tissue for genetic analysis | 19 | $289 | $14 |
| Pathology examination of tissue using a microscope, moderately low complexity | 34 | $268 | $8 |
| Cell examination of specimen, concentration technique | 15 | $263 | $16 |
Who their Medicare patients are
808 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 11% · Women 55% · Also on Medicaid 7% · Health risk score 1.44. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Coronary heart disease 33% · Diabetes 32% · Chronic kidney disease 29% · COPD 24% · Cancer 23% · Atrial fibrillation 23% · Depression 23% · Heart failure 20% · Stroke 9% · Dementia 7%.
The office billed $498,577, Medicare allowed $86,905 and paid $67,072; for 2,664 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 808 | 2,664 | 74 | 1.44 | $498,577 | $67,072 |
| 2023 | 424 | 1,609 | 74 | 1.21 | $528,138 | $63,039 |
| 2022 | 313 | 1,527 | 73 | 1.44 | $335,764 | $53,476 |
| 2021 | 446 | 2,226 | 73 | 1.67 | $362,283 | $76,194 |
| 2020 | 421 | 2,073 | 72 | 1.54 | $343,973 | $75,205 |
| 2019 | 432 | 1,641 | 71 | 1.74 | $278,316 | $61,034 |
| 2018 | 418 | 1,624 | 74 | 1.67 | $140,435 | $52,216 |
| 2017 | 734 | 2,727 | 73 | 1.42 | $301,114 | $123,639 |
| 2016 | 166 | 478 | 73 | 1.00 | $64,151 | $27,988 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Pathology examination of tissue using a microscope, moderately high complexity | 72 | $16,248 | $75 |
| Pathology examination of tissue using a microscope, intermediate complexity | 221 | $11,824 | $30 |
| Microscopic genetic analysis of tumor, manual | 76 | $9,909 | $38 |
| Special stained specimen slides to examine tissue, each additional procedure | 61 | $5,883 | $25 |
| Special stained specimen slides to examine tissue, initial procedure | 114 | $4,211 | $30 |
| Pathology examination of tissue using a microscope, intermediate complexity | 19 | $3,212 | $54 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 41 | $2,523 | $59 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 35 | $2,431 | $69 |
| Pathology examination of specimen during surgery, first tissue block | 15 | $1,171 | $56 |
| Blood smear interpretation by physician with written report | 31 | $603 | $18 |
| Preparation of tissue for examination by removing any calcium present | 37 | $416 | $10 |
| Pathology examination of tissue using a microscope, moderately low complexity | 18 | $219 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 17 | $167 | $9 |
2022: 12 services
| Pathology examination of tissue using a microscope, intermediate complexity | 210 | $11,713 | $30 |
| Pathology examination of tissue using a microscope, moderately high complexity | 60 | $10,497 | $68 |
| Special stained specimen slides to examine tissue, each additional procedure | 110 | $8,093 | $24 |
| Microscopic genetic analysis of tumor, manual | 83 | $7,997 | $35 |
| Special stained specimen slides to examine tissue, initial procedure | 144 | $4,896 | $29 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 34 | $2,610 | $75 |
| Pathology examination of specimen during surgery, first tissue block | 21 | $2,475 | $53 |
| Pathology examination of tissue using a microscope, high complexity | 15 | $1,699 | $113 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 20 | $1,277 | $58 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 25 | $783 | $28 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $562 | $21 |
| Special stained specimen slides to examine tissue including interpretation and report | 13 | $121 | $9 |
2021: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 304 | $16,480 | $31 |
| Special stained specimen slides to examine tissue, each additional procedure | 139 | $14,754 | $24 |
| Pathology examination of tissue using a microscope, moderately high complexity | 79 | $12,765 | $70 |
| Microscopic genetic analysis of tumor, manual | 70 | $6,954 | $34 |
| Pathology examination of specimen during surgery, first tissue block | 43 | $6,450 | $53 |
| Special stained specimen slides to examine tissue, initial procedure | 178 | $6,184 | $29 |
| Evaluation of fine needle aspirate with interpretation and report | 38 | $3,001 | $56 |
| Pathology examination of tissue using a microscope, high complexity | 18 | $2,237 | $124 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 29 | $1,676 | $51 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 41 | $1,624 | $32 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 17 | $1,134 | $67 |
| Cell examination of specimen, concentration technique | 36 | $689 | $18 |
| Special stained specimen slides to identify organisms including interpretation and report | 14 | $681 | $23 |
| Pathology examination of specimen during surgery, each additional tissue block | 11 | $631 | $26 |
| Special stained specimen slides to examine tissue including interpretation and report | 20 | $297 | $10 |
| Pathology examination of tissue using a microscope, moderately low complexity | 25 | $297 | $10 |
| Preparation of tissue for examination by removing any calcium present | 12 | $158 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 14 | $65 | $4 |
2020: 16 services
| Pathology examination of tissue using a microscope, intermediate complexity | 248 | $17,049 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 74 | $12,407 | $72 |
| Special stained specimen slides to examine tissue, each additional procedure | 104 | $11,355 | $25 |
| Pathology examination of specimen during surgery, first tissue block | 71 | $8,217 | $54 |
| Microscopic genetic analysis of tumor, manual | 73 | $7,328 | $37 |
| Special stained specimen slides to examine tissue, initial procedure | 145 | $5,719 | $31 |
| Pathology examination of tissue using a microscope, high complexity | 22 | $2,950 | $128 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 40 | $2,447 | $57 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 46 | $1,885 | $34 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 25 | $1,741 | $70 |
| Pathology examination of specimen during surgery, each additional tissue block | 21 | $1,309 | $27 |
| Special stained specimen slides to identify organisms including interpretation and report | 17 | $1,146 | $22 |
| Pathology examination of tissue using a microscope, moderately low complexity | 35 | $367 | $9 |
| Special stained specimen slides to examine tissue including interpretation and report | 20 | $326 | $11 |
| Preparation of tissue for examination by removing any calcium present | 24 | $281 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 15 | $65 | $3 |
2019: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 243 | $15,163 | $32 |
| Pathology examination of tissue using a microscope, moderately high complexity | 73 | $10,755 | $72 |
| Pathology examination of specimen during surgery, first tissue block | 84 | $10,360 | $54 |
| Special stained specimen slides to examine tissue, each additional procedure | 71 | $6,919 | $25 |
| Microscopic genetic analysis of tumor, manual | 39 | $3,823 | $36 |
| Special stained specimen slides to examine tissue, initial procedure | 99 | $3,599 | $30 |
| Evaluation of fine needle aspirate with interpretation and report | 43 | $3,008 | $61 |
| Pathology examination of tissue using a microscope, high complexity | 17 | $2,297 | $128 |
| Cell examination of specimen, concentration technique | 47 | $934 | $19 |
| Pathology examination of specimen during surgery, each additional tissue block | 14 | $905 | $26 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 12 | $718 | $60 |
| Special stained specimen slides to identify organisms including interpretation and report | 14 | $622 | $23 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 14 | $438 | $31 |
| Pathology examination of tissue using a microscope, moderately low complexity | 25 | $284 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 12 | $229 | $10 |
| Preparation of tissue for examination by removing any calcium present | 13 | $147 | $11 |
| Pathology examination of tissue using a microscope | 17 | $124 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 16 | $79 | $4 |
2018: 17 services
| Pathology examination of tissue using a microscope, intermediate complexity | 288 | $14,217 | $31 |
| Special stained specimen slides to examine tissue, each additional procedure | 69 | $11,367 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 61 | $6,230 | $72 |
| Special stained specimen slides to examine tissue, initial procedure | 132 | $4,901 | $31 |
| Cell examination of specimen, selective cellular enhancement technique | 103 | $2,860 | $23 |
| Pathology cytologic examination of specimen during surgery, initial site | 33 | $1,866 | $55 |
| Pathology examination of specimen during surgery, first tissue block | 23 | $1,707 | $52 |
| Special stained specimen slides to identify organisms including interpretation and report | 56 | $1,697 | $21 |
| Pathology examination of tissue using a microscope, high complexity | 11 | $1,454 | $121 |
| Evaluation of fine needle aspirate with interpretation and report | 14 | $1,381 | $99 |
| Special stained specimen slides to examine tissue including interpretation and report | 53 | $835 | $10 |
| Microscopic genetic analysis of tumor, manual | 11 | $829 | $39 |
| Evaluation of fine needle aspirate | 11 | $460 | $42 |
| Pathology examination of tissue using a microscope, moderately low complexity | 41 | $397 | $9 |
| Examination of archival tissue for genetic analysis | 15 | $290 | $16 |
| Preparation of tissue for examination by removing any calcium present | 14 | $185 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 14 | $54 | $4 |
2017: 22 services
| Pathology examination of tissue using a microscope, intermediate complexity | 516 | $31,769 | $40 |
| Special stained specimen slides to examine tissue, each additional procedure | 111 | $18,477 | $40 |
| Evaluation of fine needle aspirate with interpretation and report | 97 | $12,603 | $112 |
| Special stained specimen slides to examine tissue, initial procedure | 206 | $11,573 | $48 |
| Pathology examination of tissue using a microscope, moderately high complexity | 72 | $9,159 | $89 |
| Special stained specimen slides to identify organisms including interpretation and report | 79 | $4,758 | $45 |
| Cell examination of specimen, selective cellular enhancement technique | 141 | $4,263 | $26 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 14 | $3,986 | $266 |
| Special stained specimen slides to examine tissue including interpretation and report | 85 | $3,500 | $26 |
| Microscopic genetic analysis of tumor, manual | 13 | $2,892 | $93 |
| Evaluation of fine needle aspirate | 55 | $2,810 | $42 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 51 | $2,139 | $23 |
| Pathology cytologic examination of specimen during surgery, initial site | 33 | $1,937 | $54 |
| Fine needle aspiration using imaging guidance | 30 | $1,857 | $46 |
| Pathology examination of specimen during surgery, each additional tissue block | 12 | $1,829 | $40 |
| Pathology examination of specimen during surgery, first tissue block | 17 | $1,766 | $65 |
| Pathology examination of tissue using a microscope, moderately low complexity | 86 | $1,305 | $14 |
| Ultrasonic guidance for needle placement | 29 | $1,254 | $43 |
| New patient visit (10+ min) | 32 | $675 | $21 |
| Examination of archival tissue for genetic analysis | 17 | $302 | $16 |
| Preparation of tissue for examination by removing any calcium present | 12 | $200 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 18 | $78 | $4 |
2016: 9 services
| Pathology examination of tissue using a microscope, intermediate complexity | 82 | $4,336 | $43 |
| Pathology examination of tissue using a microscope, intermediate complexity | 33 | $2,900 | $58 |
| Pathology examination of tissue using a microscope, moderately high complexity | 12 | $2,435 | $162 |
| Evaluation of fine needle aspirate with interpretation and report | 16 | $1,756 | $110 |
| Special stained specimen slides to examine tissue, initial procedure | 26 | $1,530 | $53 |
| Special stained specimen slides to examine tissue, each additional procedure | 11 | $1,014 | $27 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $553 | $37 |
| Cell examination of specimen, selective cellular enhancement technique | 22 | $545 | $21 |
| Pathology examination of tissue using a microscope, moderately low complexity | 17 | $328 | $18 |
Medicaid work
$5,792 in 2024
Medicaid paid $5,792 for 169 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 152 | $5,563 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 17 | $229 |
| 2024 | 169 | 2 | 28 | $5,792 |
| 2023 | 73 | 2 | 22 | $2,610 |
| 2021 | 212 | 2 | 30 | $5,833 |
| 2020 | 74 | 1 | 19 | $2,491 |
| 2019 | 87 | 3 | 16 | $3,025 |
| 2018 | 401 | 5 | 38 | $16,758 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 61 | $2,392 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 12 | $217 |
2021
| TISSUE EXAM BY PATHOLOGIST | 129 | $3,784 |
| Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique) | 83 | $2,049 |
2020
| TISSUE EXAM BY PATHOLOGIST | 74 | $2,491 |
2019
| TISSUE EXAM BY PATHOLOGIST | 17 | $1,340 |
| TISSUE EXAM BY PATHOLOGIST | 42 | $1,075 |
| Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique) | 28 | $609 |
2018
| TISSUE EXAM BY PATHOLOGIST | 211 | $8,240 |
| TISSUE EXAM BY PATHOLOGIST | 65 | $5,607 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 49 | $1,589 |
| IMHCHEM/IMCYTCHM EA ADD ANTB | 12 | $714 |
| TISSUE EXAM BY PATHOLOGIST | 64 | $609 |
Money from drug and device companies
$78 in 2020
A payment is not proof that care is biased.
| Genentech USA | None | $78 | 1 payment
|
See the published payment
| Genentech USA | Meals · 2020-03-02 | None | $78 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1922388248
- Licence
- AZ 52241, CA A143605, OH 122883California A143605: Current · expires 2028-07-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZC0500X (207ZC0500X); Federal specialty code 207ZP0105X (207ZP0105X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-08-17
- NPI last updated
- 2022-09-19
- NPI record certified
- 2022-09-19
This is when the NPI record was last certified, not a medical board exam.